These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24186939)

  • 21. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990.
    Verhoeven RH; Janssen-Heijnen ML; Saum KU; Zanetti R; Caldarella A; Holleczek B; Brewster DH; Hakulinen T; Horenblas S; Brenner H; Gondos A;
    Eur J Cancer; 2013 Apr; 49(6):1414-21. PubMed ID: 23231984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year relative survival rate of uterus cancer in the USA, Europe and Japan.
    Saika K; Machii R
    Jpn J Clin Oncol; 2014 May; 44(5):513-4. PubMed ID: 24782487
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of esophageal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000).
    Qiu D; Kaneko S
    Jpn J Clin Oncol; 2005 Sep; 35(9):564-7. PubMed ID: 16199423
    [No Abstract]   [Full Text] [Related]  

  • 24. Five-year relative survival rate of bladder cancer in the USA, Europe and Japan.
    Matsuda T; Hori M
    Jpn J Clin Oncol; 2014 Aug; 44(8):776. PubMed ID: 25080514
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.
    Matsuda T; Marugame T; Kamo K; Katanoda K; Ajiki W; Sobue T;
    Jpn J Clin Oncol; 2011 Jan; 41(1):139-47. PubMed ID: 20819836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
    Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastric cancer--a comprehensive review on epidemiological and clinical data and results of treatments in Japan].
    Takasu S; Yamazaki T
    Nihon Rinsho; 1993 Jan; 51 Suppl():713-26. PubMed ID: 8459607
    [No Abstract]   [Full Text] [Related]  

  • 28. Five-year relative survival rate of testis cancer in the USA, Europe and Japan.
    Katanoda K; Matsuda T
    Jpn J Clin Oncol; 2014 Dec; 44(12):1248. PubMed ID: 25425732
    [No Abstract]   [Full Text] [Related]  

  • 29. Five-year relative survival rate of colon cancer in the USA, Europe and Japan.
    Machii R; Saika K
    Jpn J Clin Oncol; 2014 Jan; 44(1):105-6. PubMed ID: 24389292
    [No Abstract]   [Full Text] [Related]  

  • 30. International comparisons of cumulative risk of all-site cancer, from cancer incidence in five continents vol. VIII.
    Katanoda K; Qiu D
    Jpn J Clin Oncol; 2006 Jan; 36(1):66-8. PubMed ID: 16455679
    [No Abstract]   [Full Text] [Related]  

  • 31. Stomach cancer-related mortality.
    Sun J; Misumi J; Shimaoka A; Aoki K; Esaki F
    Eur J Cancer Prev; 2001 Feb; 10(1):61-7. PubMed ID: 11263592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions?
    Davis PA; Sano T
    Crit Rev Oncol Hematol; 2001 Oct; 40(1):77-94. PubMed ID: 11578917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The assessment of age-standardised cancer incidence rates in the chosen organ systems].
    Chodorowski Z; Sein Anand J; Wiśniewski M; Madaliński M
    Przegl Lek; 2007; 64(4-5):376-7. PubMed ID: 17724921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiologic trends of stomach cancer in Japan and world].
    Tominaga S
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():5-12. PubMed ID: 11424433
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper endoscopy in Europe: are we missing gastric cancer?
    Hassan C; Zullo A; Cristofari F; Lorenzetti R
    J Clin Gastroenterol; 2010 Jan; 44(1):73. PubMed ID: 19661815
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiology of cancer of the stomach.
    Yamagata S; Hisamichi S
    World J Surg; 1979 Nov; 3(6):663-9. PubMed ID: 532185
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003.
    Jézéquel J; Bessaguet C; Verveur C; Faycal J; Richert Z; Metges JP; Volant A; Nousbaum JB; Robaszkiewicz M
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1412-9. PubMed ID: 21389792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sex ratio in gastric cancer and hypothetical considerations relative to aetiology.
    Griffith GW
    Br J Cancer; 1968 Jun; 22(2):163-72. PubMed ID: 5660128
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.
    Matsuda A; Matsuda T; Shibata A; Katanoda K; Sobue T; Nishimoto H;
    Jpn J Clin Oncol; 2014 Apr; 44(4):388-96. PubMed ID: 24503029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.